SynthesisFrontiers in medicine2025

Efficacy of empagliflozin in patients with metabolic dysfunction-associated steatotic liver disease with or without diabetes: a systematic review and meta-analysis of randomized controlled trials.

Khalid I AlHussainiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.